Delivery Order SPE2DB20D3111-SPE2DB25FA9FP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,968.93 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) under a firm fixed price contract. The award, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive procurement. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order valued at $7,878.18 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This non-set-aside, competitively awarded contract reflects firm fixed pricing and was issued on August 19, 2025, with an ultimate completion date of August 20, 2025. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order valued at $3,018.48 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This non-set-aside, competitively awarded contract reflects firm fixed price terms with an ultimate completion date of September 17, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement action typical of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100, with a contract value of $9,136.01 and a completion date of September 18, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded under competitive procedures. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a $2,363.53 delivery order to AmerisourceBergen Drug Corp for Glimepiride 4 mg tablets (100-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded through an open procurement process. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units at a ceiling value of $1,606.70. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Glimepiride 4 mg tablets (100 count) with a ceiling value of $2,377.11. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is set for ultimate completion by July 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $5,207.80 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100. The contract, with an ultimate completion date of May 28, 2025, represents a competitively awarded, non-set-aside procurement with performance location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Glimepiride 4 mg tablets in a quantity of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,126.05 under firm fixed price terms, with an ultimate completion date of September 9, 2025. The delivery order was issued on September 8, 2025, and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 tablets, with a ceiling value of $2,211.04. This contract is a firm fixed price delivery order with an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the vendor's...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA9FPDelivery Order
The Defense Logistics Agency awarded a $2,237.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a small-value pharmaceutical procurement executed under a competitive, non-set-aside process. The delivery will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its primary operations as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that provides comprehensive global pharmaceutical support for military healthcare programs. As a child contract under this larger vehicle, the Glimepiride order exemplifies the company's role in supplying generic medications and critical pharmaceutical commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's federal procurement portfolio demonstrates consistent capability to fulfill competitive medical supply requirements across diverse therapeutic domains through firm fixed pricing arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/5/25 |